FDA Aims to Improve Orange Book to Boost Generic Competition

Drug Industry Daily
A A
The FDA is updating the Orange Book to make it more useful for generic drug developers, Commissioner Scott Gottlieb said Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily